Chronic Lymphocytic leukemia - Histology

What is Chronic Lymphocytic Leukemia?

Chronic Lymphocytic Leukemia (CLL) is a type of cancer that originates in the bone marrow and affects the blood. It primarily involves a clonal expansion of small, mature-appearing lymphocytes, mostly B cells. These malignant cells accumulate in the blood, bone marrow, lymph nodes, and spleen.

Histological Features

In CLL, the abnormal lymphocytes have specific histological characteristics. Under a microscope, they appear as small, round cells with scant cytoplasm and dense, clumped chromatin. One of the hallmark features is the presence of "smudge cells" (also called basket cells), which are fragile cells that rupture during slide preparation. These cells are typically seen in peripheral blood smears.

Bone Marrow Biopsy Findings

A bone marrow biopsy in CLL usually shows a hypercellular marrow with a predominance of small, mature lymphocytes. The infiltrating lymphocytes often form nodular or diffuse patterns. The marrow architecture can be disrupted, leading to a decreased production of normal blood cells.

Immunophenotyping

Immunophenotyping is crucial for diagnosing CLL. Flow cytometry is used to analyze the expression of surface markers. CLL cells typically express CD5, CD19, CD20, CD23, and low levels of surface immunoglobulins (sIg). The co-expression of CD5 and CD23 is particularly characteristic of CLL.

Cytogenetic and Molecular Features

Certain cytogenetic abnormalities are common in CLL, such as deletions in chromosomes 13q, 11q, and 17p, and trisomy 12. These genetic changes can influence the prognosis and response to treatment. For instance, the deletion of 17p, which involves the TP53 gene, is associated with a poorer prognosis.

Role of Histology in Treatment Monitoring

Histological analysis is not only essential for diagnosing CLL but also for monitoring treatment response. Post-treatment bone marrow biopsies can help assess the extent of residual disease and guide further therapeutic decisions. A decrease in the number of malignant lymphocytes and restoration of normal marrow architecture are indicative of a positive response to treatment.

Histological Differential Diagnosis

Several other conditions can mimic the histological appearance of CLL, necessitating a careful differential diagnosis. These include Mantle Cell Lymphoma, Follicular Lymphoma, and Prolymphocytic Leukemia. Immunophenotyping and genetic studies are often required to distinguish between these entities.

Conclusion

Histology plays a pivotal role in the diagnosis, classification, and management of Chronic Lymphocytic Leukemia. Understanding the histological and immunophenotypic features of CLL is essential for accurate diagnosis and effective treatment planning.



Relevant Publications

Partnered Content Networks

Relevant Topics